StockDrifts LogoStockDrifts

Oceans Bio 332190

Company
오션스바이오Oceans Bio
Insiders
0
Buys
0
Total Value
—
Avg Return
—
Last Filing
2026-03-27

Oceans Bio (332190) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Oceans Bio is dated 2025-01-14; the most recent is 2026-03-27.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-03-27BUY유상신주취득
캡스톤파트너스
Capstone Partners
-228.6K₩1,489+24.2%₩340M ($236K)
2025-03-31SELL임원퇴임
강귀염
Gangwiitis
Managing Director-37.5K₩2,690-0.4%₩101M ($70K)
2025-01-14BUY신규상장
이현웅
Hyeonwoong Lee
CEO1.2M₩8,930-69.8%₩10.4B ($7.2M)
2025-01-14BUY신규상장
강귀염
Gangwiitis
Managing Director37.5K₩8,930-69.8%₩335M ($233K)

Frequently asked questions

Who has been buying Oceans Bio stock?
0 distinct insiders have filed 0 disclosed insider purchases in Oceans Bio (332190), most recently on 2026-03-27. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Oceans Bio have?
Oceans Bio has 0 buy-side and 0 sell-side disclosures on record, spanning 2025-01-14 to 2026-03-27.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.